2014
DOI: 10.1007/s11030-014-9539-1
|View full text |Cite
|
Sign up to set email alerts
|

Design, synthesis, and biological activities of novel azole-bonded $$\upbeta $$ β -hydroxypropyl oxime O-ethers

Abstract: The synthesis and biological effects of 15 novel azole-bonded β-hydroxypropyl oxime O-ethers have been described. In this synthesis, the oximation of aromatic ketones followed by an O-alkylation reaction with epichlorohydrin and/or epibromohydrin led to the corresponding O-oxime ether adducts. Subsequently, the attained O-oxime ether adducts were used to synthesize the target molecules after treating them with the appropriate azole derivatives. The in vitro antifungal and antibacterial activities of title comp… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
7
0

Year Published

2016
2016
2020
2020

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 14 publications
(8 citation statements)
references
References 44 publications
(40 reference statements)
1
7
0
Order By: Relevance
“…Docking studies of all derivatives were implemented in the program AutoDock 4.2.6 [21]. The X-ray crystallographic structure of SE (PDB ID: 2AIB) was taken from PDB () and was invoked as a protein structure [22,23]. Beginning of docking, all the water and ligands were removed and the random hydrogen atoms were added.…”
Section: Methodsmentioning
confidence: 99%
“…Docking studies of all derivatives were implemented in the program AutoDock 4.2.6 [21]. The X-ray crystallographic structure of SE (PDB ID: 2AIB) was taken from PDB () and was invoked as a protein structure [22,23]. Beginning of docking, all the water and ligands were removed and the random hydrogen atoms were added.…”
Section: Methodsmentioning
confidence: 99%
“…Synthesis of Isolongifolenone Oxime Ether Derivatives ( 3a – 3f ). The product 3a was synthesized following the report . To a stirred soln.…”
Section: Experimental Partmentioning
confidence: 99%
“…Since the considerable therapeutic activities of N-heterocyclic compounds 70 were demonstrated and also in continuation of our interest in discovering copper(II) Schiff base complexes [71][72] and the new N-heterocyclic bioactive compounds, [73][74][75][76][77][78][79] herein we report the application of a suitable and reusable Cu(II)-curcumin complex supported on silica gel and ascorbic acid as the reducing agent. This heterogeneous catalyst system exhibits a potent catalytic activity for the synthesis of some 5-substituated-1H-tetrazole derivatives tethered to bioactive N-heterocyclic cores.…”
Section: Introductionmentioning
confidence: 99%